ConductScience.org, home

Trial · NCT01782560

Laryngomalacia Study

NCT01782560, Phase 1, Withdrawn, Children's & Women's Health Centre of British Columbia

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Laryngomalacia Study. Trials, record NCT01782560. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01782560

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Laryngomalacia Study
NCT number
NCT01782560
Status
Withdrawn
Phases
Phase 1
Enrollment
0 participants, actual
Lead sponsor
Children's & Women's Health Centre of British Columbia
Conditions
Laryngomalacia
Interventions
Omeprazole, Placebo
First posted
2013-02-04
Last updated
2015-07-30

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryLaryngomalacia Symptom ScoreChange from baseline and at end of study (baseline and 8 weeks)
This score is a disease-specific quality of life measure for laryngomalacia. Each of the symptoms that can occur in laryngomalacia are scored as present (1) or absent (0) as follows - inspiratory stridor, suprasternal retraction, substernal retraction, feeding difficulty, choking, post-feeding vomit, failure to thrive (i.e. poor weight gain with deviation from the normal growth curve), and cyanosis. Therefore for each patient, a total symptom score is calculated (8 = all symptoms, 0 = no symptoms).
SecondaryCaring For a Child with Laryngomalacia Family Impact QuestionnaireChange from baseline and at end of study (baseline and 8 weeks)
SecondaryRevised Infant Gastro-Esophageal Reflux QuestionnaireChange from baseline and at end of study (baseline and 8 weeks)
SecondaryReflux Finding ScoreChange from baseline and at end of study (baseline and 8 weeks)
SecondaryEnd of treatment 24-hour double-probe pH monitoringChange from baseline and at end of study (baseline and 8 weeks)
SecondaryWeightChange from baseline, to half-way point and at end of study (baseline, 4 weeks and 8 weeks)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers18

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
7140319BACKGROUNDPubMed
7193268BACKGROUNDPubMed
9228867BACKGROUNDPubMed
9596365BACKGROUNDPubMed
10352440BACKGROUNDPubMed
10569405BACKGROUNDPubMed
10778887BACKGROUNDPubMed
11568561BACKGROUNDPubMed
16359734BACKGROUNDPubMed
16678075BACKGROUNDPubMed

1 to 10 of 18

See all 18 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01782560

GET https://conductscience.org/api/trials/v1/NCT01782560/registered